Related Experiment Video
Updated: May 18, 2026
07:28
Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor
Published on: February 1, 2015
Safe genetic modification of cardiac stem cells using a site-specific integration technique
Feng Lan1, Junwei Liu, Kazim H Narsinh
1Department of Medicine, Division of Cardiology, Stanford School of Medicine, Stanford, CA, USA.
Circulation
|September 12, 2012
Summary
The phiC31 integrase system safely and efficiently integrates genes into human cardiac progenitor cells (hCPCs) and endothelial cells. This genetic modification improves cardiac function and limb perfusion in vivo, advancing cell-based therapies.
Area of Science:
- Regenerative Medicine
- Molecular Biology
- Cellular Engineering
Background:
- Human cardiac progenitor cells (hCPCs) show potential for myocardial infarction repair.
- Stable genetic modification of hCPCs is crucial for maximizing therapeutic benefits.
- Safe, site-specific gene integration methods are needed for enhanced cellular therapy.
Purpose of the Study:
- To evaluate the phiC31 integrase system for site-specific gene integration in hCPCs and human endothelial cells.
- To assess the safety and efficacy of genetically modified hCPCs for cardiac repair.
- To demonstrate the therapeutic potential of modified endothelial cells for peripheral perfusion.
Main Methods:
- Utilized the phiC31 site-specific recombinase for targeted transgene integration into hCPCs and endothelial cells.
- Assessed genomic stability and cell phenotype post-modification.
- Evaluated therapeutic efficacy through in vitro and in vivo studies, including echocardiography, MRI, and laser Doppler imaging.
Main Results:
- phiC31-mediated gene integration resulted in stable reporter gene expression without genomic instability or adverse phenotypic changes in hCPCs.
- Genetically modified hCPCs significantly improved myocardial function post-transplantation.
- Modified endothelial cells enhanced hind limb perfusion in vivo.
Conclusions:
- The phiC31 integrase system provides a safe and efficient method for site-specific gene integration in progenitor and differentiated cells.
- This technology enhances the therapeutic potential of cell-based regenerative strategies.
- phiC31 integration facilitates robust cell tracking and functional assessment for cellular therapies.
